Related Experiment Video
Updated: Jun 5, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Advances in pediatric rheumatology.
Canadian Family Physician Medecin De Famille Canadien
|January 15, 2011
Summary
Pediatric rheumatology has advanced, improving diagnosis and care for childhood rheumatic diseases. Focused research and increased physician awareness lead to better classification, diagnostics, and treatment.
Area of Science:
- Pediatric Rheumatology
- Childhood Autoimmune Diseases
Background:
- Increasing recognition of rheumatic diseases in children.
- Emergence of pediatric rheumatology as a subspecialty.
- Need for comprehensive patient assessment and coordinated care.
Purpose of the Study:
- To highlight advancements in pediatric rheumatology.
- To underscore the impact of focused research.
- To emphasize the importance of physician awareness.
Main Methods:
- Review of advancements in pediatric rheumatology.
- Analysis of research contributions.
- Assessment of physician awareness impact.
Main Results:
- Improved disease classification in pediatric rheumatology.
- Development of sophisticated diagnostic tests.
- More judicious use of pharmacologic therapies.
- Earlier diagnosis and improved care for children.
Conclusions:
- Pediatric rheumatology advancements have significantly improved patient outcomes.
- Focused research and increased awareness are key drivers of progress.
- Comprehensive and coordinated care is essential for managing childhood rheumatic diseases.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...